125 related articles for article (PubMed ID: 16202737)
1. Patient preference regarding first-trimester aneuploidy risk assessment.
Sharma G; Gold HT; Chervenak FA; McCullough L; Alt AK; Chasen ST
Am J Obstet Gynecol; 2005 Oct; 193(4):1429-36. PubMed ID: 16202737
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
Spencer K; Aitken D
Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
[TBL] [Abstract][Full Text] [Related]
3. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
4. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
5. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
Chan LW; Chau MC; Leung TY; Fung TY; Leung TN; Lau TK
Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
[TBL] [Abstract][Full Text] [Related]
6. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
[TBL] [Abstract][Full Text] [Related]
7. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
Sharma G; McCullough LB; Chervenak FA
Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
[TBL] [Abstract][Full Text] [Related]
8. Patient and health professional acceptance of integrated serum screening for Down syndrome.
Palomaki GE; Kloza EM; Haddow JE; Williams J; Knight GJ
Semin Perinatol; 2005 Aug; 29(4):247-51. PubMed ID: 16104676
[TBL] [Abstract][Full Text] [Related]
9. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
10. First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation.
Philipson EH; Callahan M; Jelovsek JE
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):218-22. PubMed ID: 18669714
[TBL] [Abstract][Full Text] [Related]
11. Comparison of first and second trimester aneuploidy risk assessment.
Reddy UM; Wapner RJ
Clin Obstet Gynecol; 2007 Jun; 50(2):442-53. PubMed ID: 17513930
[TBL] [Abstract][Full Text] [Related]
12. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
13. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
14. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Skotko B
Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429
[No Abstract] [Full Text] [Related]
15. First-trimester aneuploidy risk assessment: the impact of comprehensive counseling and same-day results on patient satisfaction, anxiety, and knowledge.
Fox NS; Rebarber A; Klauser CK; Roman AS; Saltzman DH
Am J Perinatol; 2011 Jan; 28(1):13-8. PubMed ID: 20607646
[TBL] [Abstract][Full Text] [Related]
16. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
17. [How to improve the screening and diagnosis of fetal aneuploidy?].
Ville Y
Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
[TBL] [Abstract][Full Text] [Related]
18. Stepwise sequential screening for fetal aneuploidy.
Benn PA; Campbell WA; Zelop CM; Ingardia C; Egan JF
Am J Obstet Gynecol; 2007 Sep; 197(3):312.e1-5. PubMed ID: 17826434
[TBL] [Abstract][Full Text] [Related]
19. Integrated serum screening for Down syndrome in primary obstetric practice.
Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
[TBL] [Abstract][Full Text] [Related]
20. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
